Quick Takeaways
- SR One Capital Fund I Aggregator LP filed SCHEDULE 13D/A for Design Therapeutics, Inc. Common Stock, $0.0001 par value per share (DSGN).
- Disclosed ownership: 11%.
- Date of event: 09 Mar 2026.
Quoteable Key Fact
"SR One Capital Fund I Aggregator LP disclosed 11% ownership in Design Therapeutics, Inc. Common Stock, $0.0001 par value per share (DSGN) on 09 Mar 2026."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| SR One Capital Fund I Aggregator, LP | 11% | 6,526,476 | 0 | 6,526,476 | /s/ Sasha Keough | Sasha Keough, as attorney-in-fact for Simeon George, M.D., Managing Member | 0001848319 |
| SR One Capital Partners I, LP | 11% | 6,526,476 | 0 | 6,526,476 | /s/ Sasha Keough | Sasha Keough, as attorney-in-fact for Simeon George, M.D., Managing Member | |
| SR One Capital Management, LLC | 11% | 6,526,476 | 0 | 6,526,476 | /s/ Sasha Keough | Sasha Keough, as attorney-in-fact for Simeon George, M.D., Managing Member | |
| Simeon George | 11% | 6,607,892 | 81,416 | 6,526,476 | /s/ Sasha Keough | Sasha Keough, as attorney-in-fact for Simeon George, M.D., Managing Member |